502 related articles for article (PubMed ID: 22821214)
1. Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome.
Schneider HE; Steinmetz M; Krause U; Kriebel T; Ruschewski W; Paul T
Clin Res Cardiol; 2013 Jan; 102(1):33-42. PubMed ID: 22821214
[TBL] [Abstract][Full Text] [Related]
2. Left cardiac sympathetic denervation in the management of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: A meta-regression.
Sgrò A; Drake TM; Lopez-Ayala P; Phan K
Congenit Heart Dis; 2019 Nov; 14(6):1102-1112. PubMed ID: 31621201
[TBL] [Abstract][Full Text] [Related]
3. Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias.
Hofferberth SC; Cecchin F; Loberman D; Fynn-Thompson F
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):404-9. PubMed ID: 24268954
[TBL] [Abstract][Full Text] [Related]
4. Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery.
Collura CA; Johnson JN; Moir C; Ackerman MJ
Heart Rhythm; 2009 Jun; 6(6):752-9. PubMed ID: 19467503
[TBL] [Abstract][Full Text] [Related]
5. Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders.
Bos JM; Bos KM; Johnson JN; Moir C; Ackerman MJ
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):705-11. PubMed ID: 23728945
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
7. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.
Sy RW; Gollob MH; Klein GJ; Yee R; Skanes AC; Gula LJ; Leong-Sit P; Gow RM; Green MS; Birnie DH; Krahn AD
Heart Rhythm; 2011 Jun; 8(6):864-71. PubMed ID: 21315846
[TBL] [Abstract][Full Text] [Related]
8. Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense Mutation.
Nozaki Y; Kato Y; Uike K; Yamamura K; Kikuchi M; Yasuda M; Ohno S; Horie M; Murayama T; Kurebayashi N; Horigome H
Circ J; 2020 Jan; 84(2):226-234. PubMed ID: 31875585
[TBL] [Abstract][Full Text] [Related]
9. Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.
Roston TM; Vinocur JM; Maginot KR; Mohammed S; Salerno JC; Etheridge SP; Cohen M; Hamilton RM; Pflaumer A; Kanter RJ; Potts JE; LaPage MJ; Collins KK; Gebauer RA; Temple JD; Batra AS; Erickson C; Miszczak-Knecht M; Kubuš P; Bar-Cohen Y; Kantoch M; Thomas VC; Hessling G; Anderson C; Young ML; Cabrera Ortega M; Lau YR; Johnsrude CL; Fournier A; Kannankeril PJ; Sanatani S
Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):633-42. PubMed ID: 25713214
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of 30 cases of inherited cardiac arrhythmia syndrome in children].
Li ZL; Zeng SY; Liang DP; Liu T; Wang SS; Zhang ZW
Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):700-704. PubMed ID: 31530356
[No Abstract] [Full Text] [Related]
11. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
[TBL] [Abstract][Full Text] [Related]
12. Mechanism underlying catecholaminergic polymorphic ventricular tachycardia and approaches to therapy.
Watanabe H; Knollmann BC
J Electrocardiol; 2011; 44(6):650-5. PubMed ID: 21872879
[TBL] [Abstract][Full Text] [Related]
13. Physical and Psychological Consequences of Left Cardiac Sympathetic Denervation in Long-QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia.
Waddell-Smith KE; Ertresvaag KN; Li J; Chaudhuri K; Crawford JR; Hamill JK; Haydock D; Skinner JR;
Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1151-8. PubMed ID: 26224781
[TBL] [Abstract][Full Text] [Related]
14. Sudden cardiac arrest during sex in patients with either catecholaminergic polymorphic ventricular tachycardia or long-QT syndrome: a rare but shocking experience.
Loar RW; Bos JM; Cannon BC; Ackerman MJ
J Cardiovasc Electrophysiol; 2015 Mar; 26(3):300-4. PubMed ID: 25514987
[TBL] [Abstract][Full Text] [Related]
15. Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.
De Ferrari GM; Dusi V; Spazzolini C; Bos JM; Abrams DJ; Berul CI; Crotti L; Davis AM; Eldar M; Kharlap M; Khoury A; Krahn AD; Leenhardt A; Moir CR; Odero A; Olde Nordkamp L; Paul T; Rosés I Noguer F; Shkolnikova M; Till J; Wilde AA; Ackerman MJ; Schwartz PJ
Circulation; 2015 Jun; 131(25):2185-93. PubMed ID: 26019152
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature.
Pott C; Dechering DG; Reinke F; Muszynski A; Zellerhoff S; Bittner A; Köbe J; Wasmer K; Schulze-Bahr E; Mönnig G; Kotthoff S; Eckardt L
Europace; 2011 Jun; 13(6):897-901. PubMed ID: 21292648
[TBL] [Abstract][Full Text] [Related]
17. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome.
Schwartz PJ; Priori SG; Cerrone M; Spazzolini C; Odero A; Napolitano C; Bloise R; De Ferrari GM; Klersy C; Moss AJ; Zareba W; Robinson JL; Hall WJ; Brink PA; Toivonen L; Epstein AE; Li C; Hu D
Circulation; 2004 Apr; 109(15):1826-33. PubMed ID: 15051644
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.
Kaufman ES
Heart Rhythm; 2009 Aug; 6(8 Suppl):S51-5. PubMed ID: 19631908
[TBL] [Abstract][Full Text] [Related]
19. Primary prevention with the implantable cardioverter-defibrillator in high-risk long-QT syndrome patients.
Biton Y; Rosero S; Moss AJ; Goldenberg I; Kutyifa V; McNitt S; Polonsky B; Baman JR; Zareba W
Europace; 2019 Feb; 21(2):339-346. PubMed ID: 29947754
[TBL] [Abstract][Full Text] [Related]
20. Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome.
Coleman MA; Bos JM; Johnson JN; Owen HJ; Deschamps C; Moir C; Ackerman MJ
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):782-8. PubMed ID: 22787014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
